Spermicide Nonoxynol-9 Gets Fda Admonishing
The FDA today ordered a new admonishing for the spermicide nonoxynol-9 in over-the-counter gels, foams, films, or inserts.
Those products' labels have to now cover these warnings:
- Nonoxynol-9 doesn't assure adjoin HIV or added sexually transmitted diseases (STDs)
- Nonoxynol-9 may abrade the vagina and rectum, which may access the accident of application HIV/AIDS from an adulterated partner.
The FDA fabricated the aphorism to "correct misconceptions that the actinic N9 in these broadly accessible stand-alone contraceptive articles protects adjoin sexually transmitted diseases, including HIV infection," Janet Woodcock, MD, says in a account release.
"Clinical analysis has apparent that N9 provides no aegis adjoin sexually transmitted diseases to the woman if her animal accomplice is adulterated with an STD antibody or HIV," says Woodcock, who is the FDA's agent abettor for accurate and medical program, arch medical officer, and acting administrator for the FDA's Center for Drug Evaluation and Research.
The FDA aboriginal proposed new warnings for nonoxynol-9 about 5 years ago, afterwards a abstraction from Africa and Thailand showed that women application a contraceptive gel artefact absolute N9 weren't adequate adjoin HIV and added STDs and were added acceptable to advance HIV infection than women application a placebo gel.